Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies - Concepedia

Concepedia

Publication | Open Access

Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies

DOI Full Paper Access

43

Citations

57

References

2019

Year

José Medina‐Echeverz, Maria Hinterberger, Marco Testori, Marlene Geiger, Raphael Giessel, Barbara Bathke, Ronny Kassub, Fabienne Gräbnitz, Giovanna Fiore, Sonia Wennier,

Nature Communications

References

	Year	Citations

Page 1